About This Study
The purpose of this study is to see if a new type of inhaler with a different ingredient is safe and works well for patients with asthma. The new inhaler has a substance called HFA-152a, which the FDA hasn't approved yet. We'll compare it to the current inhaler called Ventolin, which has HFA-134a.
Volunteers must be diagnosed with asthma for 6 months or longer. Study team will provide more information.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
- Diary/e-Diary Writing or Recordings
Age & Gender
- 12 - 100 years old
- All Genders
Language
- This study enrolls English speakers only
Additional Study Information
- Compensation Offered
- Reimbursement offered
Study Locations
- Greater Winston-Salem, NC